drugset / Trial / NCT03192826
Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
RandomizedParallel-groupDouble-blindPrevention
Summary
To compare the efficacy of a Brinzolamide/Brimonidine fixed combination (FC) with Brimonidine 0.2% in preventing intraocular pressure (IOP) elevations after neodymium: yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy.
Timeline
- Start
- 2016-06-20
- Primary completion
- 2017-07-08
- Completion
- 2017-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Small molecule | 0.2 % | — |
| Comparator | Brinzolamide/Brimonidine | Unknown | 0.2 % | — |
| Comparator | Brinzolamide/Brimonidine | Unknown | 1 % | — |